Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 70710-2058

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 70710-2058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Chemical Structure Of Sevelamer Hydrochloride (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 01)

Chemical structure diagram of Sevelamer Hydrochloride showing the polymer network with primary amine groups, crosslinking groups, and fraction of protonated amines. The diagram includes annotations specifying the number of amine groups and crosslinking parameters.*

FDA Label Image

Image (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 02)

A line graph showing the percentage of patients with at least a 2-fold reduction in serum phosphorus levels, comparing Sevelamer Hydrochloride to an active control. The x-axis represents reduction in serum phosphorus (mg/dL) ranging from -4 to 8, while the y-axis shows the percentage of patients from 0 to 100%. The graph indicates patient response performance for both treatments over the range of phosphorus reduction.*

FDA Label Image

Image (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 03)

A line graph showing the change in phosphorus levels from baseline over 52 study weeks. The x-axis represents study weeks, and the y-axis shows phosphorus change. Two treatment groups are compared: Sevelamer Hydrochloride and Active-Control, each represented by distinct markers and lines.*

FDA Label Image

Pdp-bottle (F9b9e637 D236 4bc0 Afca Bbbf1b1747ab 04)

Label for Sevelamer Hydrochloride tablets 800 mg, film-coated oral tablets. The label states the active ingredient strength as 800 mg and indicates a package size of 180 tablets. It is distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage instructions and a barcode with NDC 70710-2058-8.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.